Free Access
Issue
Med Sci (Paris)
Volume 31, Number 6-7, Juin–Juillet 2015
Page(s) 589 - 591
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20153106005
Published online 07 July 2015
  1. Reichenberger EJ, Levine MA, Olsen BR, et al. The role of SH3BP2 in the pathophysiology of cherubism. Orphanet J Rare Dis 2012 ; 7 : S5. [CrossRef] [PubMed] [Google Scholar]
  2. Deckert M, Tartare-Deckert S, Hernandez J, et al. Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. Immunity 1998 ; 9 : 595–605. [CrossRef] [PubMed] [Google Scholar]
  3. Deckert M. L’adaptateur 3BP2. Quelle place pour cette protéine dans la signalisation des leucocytes ? Med Sci (Paris) 2006 ; 22 : 1081–1086. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. GuezGuez A, Prod’homme V, Mouska X, et al. 3BP2 Adapter protein is required for receptor activator of NFkappaB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells.. J Biol Chem 2010 ; 285 : 20952–20963. [CrossRef] [PubMed] [Google Scholar]
  5. Ueki Y, Lin CY, Senoo M, et al. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 cherubism mice. Cell 2007 ; 128 : 71–83. [CrossRef] [PubMed] [Google Scholar]
  6. Prod’Homme V, Boyer L, Dubois N, et al. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages. J Clin Invest 2015 ; 125 : 1396–1400. [CrossRef] [PubMed] [Google Scholar]
  7. Levaot N, Voytyuk O, Dimitriou I, et al. Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. Cell 2011 ; 147 : 1324–1339. [CrossRef] [PubMed] [Google Scholar]
  8. Graves DT, Li J, Cochran DL. Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res 2011 ; 90 : 143–153. [CrossRef] [PubMed] [Google Scholar]
  9. Yoshitaka T, Mukai T, Kittaka M, et al. Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism. Cell Rep 2014 ; 8 : 1752–1766. [CrossRef] [PubMed] [Google Scholar]
  10. Kadlub N, Vazquez MP, Galmiche L, et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. J Bone Miner Res 2014 ; 30 : 878–885. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.